
Global Cord Blood Corporation CO
Annual report 2022
added 08-16-2022
Global Cord Blood Corporation DSO Ratio 2011-2025 | CO
Annual DSO Ratio Global Cord Blood Corporation
| 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 112 | 96.3 | 69.6 | 39.8 | 45.6 | 56.6 | 72.5 | 72.4 | 71.2 | 52.2 | 75.8 | 84.5 |
All numbers in CNY currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 112 | 39.8 | 70.7 |
Quarterly DSO Ratio Global Cord Blood Corporation
| 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| - | - | - | - | - | 21 | - | - | - | 19.4 | - | - | - | 14.1 | - | - | - | 19.3 | - | - | - | 21.7 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 50.2 | 141 | - | - | 56.5 | 164 | 189 | 77.5 | 37.6 | 40.4 | - |
All numbers in CNY currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| 189 | 14.1 | 65.5 |
DSO Ratio of other stocks in the Diagnostics research industry
| Issuer | DSO Ratio | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
|
Centogene N.V.
CNTG
|
145 | - | -6.23 % | $ 30.6 M | ||
|
Akumin
AKU
|
57.4 | - | -17.87 % | $ 25.9 M | ||
|
DarioHealth Corp.
DRIO
|
85.8 | $ 11.98 | 0.76 % | $ 340 M | ||
|
DexCom
DXCM
|
85 | $ 66.7 | -0.39 % | $ 25.7 B | ||
|
Burning Rock Biotech Limited
BNR
|
31.7 | $ 16.71 | 6.1 % | $ 180 M | ||
|
Exact Sciences Corporation
EXAS
|
29.9 | $ 101.53 | 0.03 % | $ 18.8 B | ||
|
Accelerate Diagnostics
AXDX
|
291 | - | -61.36 % | $ 2.46 M | ||
|
Biocept
BIOC
|
112 | - | -13.05 % | $ 7.29 M | ||
|
BioNano Genomics
BNGO
|
83.4 | $ 1.59 | -1.91 % | $ 2.02 M | ||
|
IQVIA Holdings
IQV
|
78 | $ 222.65 | 0.18 % | $ 40.4 B | ||
|
Oxford Immunotec Global PLC
OXFD
|
90.8 | - | - | $ 562 M | ||
|
Castle Biosciences
CSTL
|
49.2 | $ 38.47 | -0.41 % | $ 1.07 B | ||
|
Chembio Diagnostics
CEMI
|
66.3 | - | 0.22 % | $ 16.8 M | ||
|
Danaher Corporation
DHR
|
57 | $ 226.5 | 0.08 % | $ 166 B | ||
|
Fulgent Genetics
FLGT
|
77.4 | $ 26.81 | -1.22 % | $ 811 M | ||
|
Fluidigm Corporation
FLDM
|
67.2 | - | 1.08 % | $ 308 M | ||
|
Genetic Technologies Limited
GENE
|
11.7 K | - | - | $ 7.1 B | ||
|
Genetron Holdings Limited
GTH
|
122 | - | 0.12 % | $ 80.1 M | ||
|
Mettler-Toledo International
MTD
|
63.7 | $ 1 415.66 | 1.58 % | $ 30 B | ||
|
DermTech
DMTK
|
80.6 | - | -11.32 % | $ 2.94 M | ||
|
PRA Health Sciences, Inc.
PRAH
|
98.1 | - | - | $ 10.7 B | ||
|
Myriad Genetics
MYGN
|
51.3 | $ 7.01 | -2.77 % | $ 635 M | ||
|
NeoGenomics
NEO
|
77.8 | $ 12.08 | 1.94 % | $ 1.53 B | ||
|
Neogen Corporation
NEOG
|
66.6 | $ 6.83 | -0.51 % | $ 1.48 B | ||
|
CareDx, Inc
CDNA
|
76.4 | $ 19.96 | -2.92 % | $ 1.07 B | ||
|
Enzo Biochem
ENZ
|
50.3 | - | -8.98 % | $ 14.8 K | ||
|
Anixa Biosciences
ANIX
|
385 | $ 3.56 | -0.7 % | $ 114 K | ||
|
Co-Diagnostics
CODX
|
101 | $ 0.31 | -9.02 % | $ 9.1 M | ||
|
Pacific Biosciences of California
PACB
|
50.4 | $ 2.11 | -0.71 % | $ 535 M | ||
|
Quidel Corporation
QDEL
|
116 | $ 28.87 | 0.24 % | $ 1.22 B | ||
|
Guardant Health
GH
|
49.2 | $ 104.86 | 2.73 % | $ 12.9 B | ||
|
Precipio
PRPO
|
28.1 | $ 24.68 | -1.14 % | $ 32 M | ||
|
QIAGEN N.V.
QGEN
|
30.8 | $ 45.24 | 0.04 % | $ 10.1 B | ||
|
Aspira Women's Health
AWH
|
50.7 | - | -6.19 % | $ 10.5 M | ||
|
Sotera Health Company
SHC
|
47.8 | $ 16.81 | -0.15 % | $ 4.75 B | ||
|
Heska Corporation
HSKA
|
40.8 | - | - | $ 1.31 B | ||
|
Soleno Therapeutics
SLNO
|
33.5 | $ 51.43 | -1.1 % | $ 2.07 B | ||
|
HTG Molecular Diagnostics
HTGM
|
101 | - | -20.0 % | $ 1.06 M | ||
|
Illumina
ILMN
|
61.3 | $ 134.29 | -0.43 % | $ 21.4 B | ||
|
Charles River Laboratories International
CRL
|
67.7 | $ 196.55 | 1.82 % | $ 10.1 B | ||
|
Quotient Limited
QTNT
|
45.1 | - | -11.32 % | $ 1.1 M | ||
|
Thermo Fisher Scientific
TMO
|
69.9 | $ 567.34 | -0.76 % | $ 217 B | ||
|
Trinity Biotech plc
TRIB
|
87.2 | $ 1.08 | 0.93 % | $ 61.9 M | ||
|
Twist Bioscience Corporation
TWST
|
44.5 | $ 31.12 | 0.61 % | $ 1.86 B | ||
|
Quest Diagnostics Incorporated
DGX
|
46.5 | $ 183.54 | 0.54 % | $ 20.4 B | ||
|
Biodesix
BDSX
|
41.7 | $ 7.76 | -1.15 % | $ 1.01 B |